T. Utsunomiya, Den-ichiro Yamaoka, T. Asakawa, Yukio Mizumoto, Yasutsugu Takada
{"title":"Successful treatment of an older patient with COVID‐19 pneumonia using herbal medicine—especially saikanto","authors":"T. Utsunomiya, Den-ichiro Yamaoka, T. Asakawa, Yukio Mizumoto, Yasutsugu Takada","doi":"10.1002/tkm2.1379","DOIUrl":null,"url":null,"abstract":"New antiviral drugs for COVID-19 have been launched with special approval. However, as there may be a shortage of drugs in the future, it may be difficult to provide appropriate medical intervention. Herein, we describe our experience of successfully treating COVID-19 pneumonia in an older patient using a Japanese herbal medicine without new antiviral drugs. A 94-year-old woman was diagnosed with COVID-19 and received home care. However, dyspnea appeared on day 4 of home treatment, so she visited the emergency department of our hospital. Her SpO2 then increased to 97% after oxygen delivery at a rate of 7 L/min via a mask. On physical examination, the patient presented with tachypnea (24 breaths per minute) and stable hemodynamics. Her blood pressure, heart rate, and body temperature were 104/65 mm Hg, 68 beats/min, and 37.5 C respectively. She had clear consciousness. Her height and body weight were 146 cm and 47 kg respectively. Laboratory test results are presented in Table 1. Computed tomography (CT) scan revealed infiltrates in the bilateral lower lungs with ground-glass signs. The qSOFA was one point and sepsis was not actively suspected, but the A-DROP was three points and the patient was indicated for hospitalization for severe pneumonia. Given her history of hypertension and stroke, she usually spent most of her time lying in bed, except for eating and defecating. Aspiration was not confirmed during home care. CT imaging showed mainly a groundglass appearance rather than an infiltrating shadow, so aspiration pneumonia was not actively suspected. Based on the course and CT imaging, typical bacterial pneumonia was not actively suspected and the use of antibiotics was withheld. Her respiration was stabilized with oxygen therapy; however, she was frail and old, and neither she nor her family wanted active treatment. As she could drink water, a Japanese herbal treatment for pneumonia was initiated. Her Kampo medical findings indicated that she had a deficiency. She complained of bitterness in her mouth and chest pain when coughing. Her pulse was weak","PeriodicalId":23213,"journal":{"name":"Traditional & Kampo Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Traditional & Kampo Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tkm2.1379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
New antiviral drugs for COVID-19 have been launched with special approval. However, as there may be a shortage of drugs in the future, it may be difficult to provide appropriate medical intervention. Herein, we describe our experience of successfully treating COVID-19 pneumonia in an older patient using a Japanese herbal medicine without new antiviral drugs. A 94-year-old woman was diagnosed with COVID-19 and received home care. However, dyspnea appeared on day 4 of home treatment, so she visited the emergency department of our hospital. Her SpO2 then increased to 97% after oxygen delivery at a rate of 7 L/min via a mask. On physical examination, the patient presented with tachypnea (24 breaths per minute) and stable hemodynamics. Her blood pressure, heart rate, and body temperature were 104/65 mm Hg, 68 beats/min, and 37.5 C respectively. She had clear consciousness. Her height and body weight were 146 cm and 47 kg respectively. Laboratory test results are presented in Table 1. Computed tomography (CT) scan revealed infiltrates in the bilateral lower lungs with ground-glass signs. The qSOFA was one point and sepsis was not actively suspected, but the A-DROP was three points and the patient was indicated for hospitalization for severe pneumonia. Given her history of hypertension and stroke, she usually spent most of her time lying in bed, except for eating and defecating. Aspiration was not confirmed during home care. CT imaging showed mainly a groundglass appearance rather than an infiltrating shadow, so aspiration pneumonia was not actively suspected. Based on the course and CT imaging, typical bacterial pneumonia was not actively suspected and the use of antibiotics was withheld. Her respiration was stabilized with oxygen therapy; however, she was frail and old, and neither she nor her family wanted active treatment. As she could drink water, a Japanese herbal treatment for pneumonia was initiated. Her Kampo medical findings indicated that she had a deficiency. She complained of bitterness in her mouth and chest pain when coughing. Her pulse was weak
新冠病毒抗病毒药物已获特别批准上市。然而,由于将来可能出现药物短缺,可能难以提供适当的医疗干预。在此,我们描述了我们使用日本草药成功治疗老年患者COVID-19肺炎的经验,没有新的抗病毒药物。一名94岁的妇女被诊断出患有COVID-19并接受了家庭护理。然而,在家庭治疗的第4天出现呼吸困难,因此她来到了我院的急诊科。通过面罩以7l /min的速率给氧后,她的SpO2增加到97%。体格检查时,患者出现呼吸急促(每分钟24次呼吸),血流动力学稳定。她的血压、心率和体温分别为104/65 mm Hg、68次/分和37.5℃。她有清醒的意识。她的身高和体重分别为146厘米和47公斤。实验室测试结果见表1。计算机断层扫描显示双侧下肺浸润伴磨玻璃征。qSOFA为1分,未积极怀疑脓毒症,但A-DROP为3分,患者因严重肺炎需要住院治疗。考虑到她有高血压和中风病史,除了吃饭和排便,她通常大部分时间都躺在床上。在家庭护理期间未确认误吸。CT主要表现为磨砂样影,未见浸润影,不积极怀疑吸入性肺炎。根据病程及CT表现,未积极怀疑为典型细菌性肺炎,未给予抗生素治疗。氧疗稳定了她的呼吸;然而,她年老体弱,她和她的家人都不希望积极治疗。因为她可以喝水,所以开始使用日本草药治疗肺炎。她的康坡医学检查结果表明,她有缺陷。她说嘴里有苦味,咳嗽时胸痛。她的脉搏很微弱